How a global crisis changed the way we test drugs episode artwork

EPISODE · Aug 24, 2022 · 13 MIN

How a global crisis changed the way we test drugs

from Science For Care · host Healthtech For Care

Back in 2019, if you had asked someone what a clinical trial is, they would probably have looked at you as if you were speaking in a foreign language. Fast forward to the post-Covid-19 era and most people not only know what a clinical trial is, but they can also likely tell you how it works: individuals, whether healthy or sick, volunteer to test a new drug in a controlled environment for a certain period of time. Before Covid, most clinical trials were conducted in hospitals, with strictly planned follow-up visits over a period of time that could stretch to several years. However, with Covid, came the need for speed and this entire model had to be rethought. This was a big headache for all those involved. We will take a look at an example of a tech-based solution that is changing the way clinical trials are performed: Cellbox. You will listen to Kathrin Adlkofer, the founder of the company, as she gives us a quick explanation of her innovation. More info Clinical trial definition A clinical trial, or clinical study, or therapeutic trial, is a scientific study conducted on human subjects with the goal of assessing the efficacy and tolerance of a treatment.  Clinical trial phases There are 3 main phases of clinical trials. Phase I Identifying treatment toxicity At this stage, the trials are mainly conducted on a limited number of healthy subjects under strict medical supervision. The molecule is tested over a short period. The objective is: - to evaluate the safety of the product, its fate in the body, its tolerance threshold; - to define the dose and frequency of administration that will be recommended for the subsequent studies. Phase II To demonstrate the efficacy of the treatment and define the optimal dose Trials are performed on 40 to 80 patients. The objective is to confirm the preliminary clinical and/or pharmacological activity of the drug at the dose recommended in Phase I. Phase III Compare the efficacy of the new drug to placebo or a reference drug if available reference drug if available Conducted on large patient populations (several hundred or thousands). These trials are very often multicentric (conducted in many study centers, hospitals). study centers, hospitals). The trials compare the therapeutic efficacy of the molecule with the reference treatment (when it exists) or to a placebo (when no therapy exists). Science for Care is a podcast by HealthTech for Care, a non profit organization designed to support and promote access to care for all. If you enjoy our show, please mention it to your friends, family and co-workers, and leave ratings and reviews on your favorite listening platform. Production: MedShake Studio  Hosted on Ausha. See ausha.co/privacy-policy for more information.

Episode metadata supplied by the publisher feed · Published Aug 24, 2022

Embed this episode

NOW PLAYING

How a global crisis changed the way we test drugs

0:00 13:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science For Care?

This episode is 13 minutes long.

When was this Science For Care episode published?

This episode was published on August 24, 2022.

Can I download this Science For Care episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!